VERQUVO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Vericiguat.
| Product ID | 0006-5028_15049ae3-29b9-496a-bf12-350978af10bb |
| NDC | 0006-5028 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VERQUVO |
| Generic Name | Vericiguat |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-02-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA214377 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | VERICIGUAT |
| Active Ingredient Strength | 3 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-5028 | VERQUVO | vericiguat |
| 0006-5029 | VERQUVO | vericiguat |
| 0006-5030 | VERQUVO | vericiguat |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VERQUVO 90764015 not registered Live/Pending |
Bayer Aktiengesellschaft 2021-06-09 |
![]() VERQUVO 87952816 5810492 Live/Registered |
Bayer Aktiengesellschaft 2018-06-07 |